Medical Hypotheses
Volume 55, Issue 5 , Pages 440-444 , November 2000

Body temperature as a risk factor for Alzheimer’s disease

  • A. Holtzman

      Affiliations

    • Elwyn Inc.; formerly of Delaware Alzheimer’s Society, Delaware, USA
    • ,
  • E.W. Simon

      Affiliations

    • Elwyn Inc. Elwyn, Pennsylvania, USA

Received 7 June 1999 ,Accepted 29 November 1999.

References 

    REFERENCES
  1. Evans DA, Funkenstein HH, Albert MS. Prevalence of Alzheimer’s disease in a community population of older persons. JAMA. 1989;262:18
  2. Selkoe, D. J. Plenary lecture Fifth International Conference on AD, Osaka Japan, 1997.
  3. Younkin SG. Evidence that A beta 42 is the real culprit in Alzheimer’s disease. Ann Neurol. 1995;37:287–288
  4. Hartmann T, Breger SC, Bruhl B. Distinct sites of intracellular production for Alzheimer’s disease A beta 40/42 amyloid peptides. Nat Med. 1997;3:1016
  5. Trojanowski JQ, Shin RW, Schmidt ML, Lee VM-Y. Relationship between plaques, tangles, and dystrophic processes in Alzheimer’s disease. Neurobiol Aging. 1995;16:335–345
  6. Sandbrink R, Hartmann T, Masters CL, Beyreuther K. Genes contributing to Alzheimer’s disease. Mol Psychiatry. 1996;1:27–40
  7. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer’s disease. Ann Rev Neurosci. 1996;19:53–77
  8. Fox RH, Woodward PM, Exton-Smith AN. Body temperature in the elderly. Br Med J. 1973;Jan:200–206
  9. Keilsen L, Lambert D, Fabian D. Screening for hypothermia in the ambulatory elderly. The Maine experience. JAMA. 1985;254:1781–1784
  10. Evans, J. C. Williams, T. F. Oxford Textbook of Geriatric Medicine. Oxford, Oxford University Press, 1992, 93, 97
  11. Wongsurawat N, Davis BB, Morley JE. Thermoregulatory failure in the elderly. J Am Ger Soc. 1990;38:899–906
  12. Morley JE, Silver A, Fiatrone M. UCLA grand rounds: nutrition and the elderly. J Am Ger Soc. 1986;34:823
  13. Holtzman A. Thermoregulation and Alzheimer’s disease. J Am Ger Soc. 1992;40:1185–1186
  14. Selkoe DJ. Amyloid protein and Alzheimer’s disease. Sci Am. 1991;Nov:68–78
  15. Ginsberg L, Xuereb JH, Gershfeld NL. Membrane instability, plasmalogen content, and Alzheimer’s disease. J Neurochem. 1998;70:2533–2538
  16. McGeer P, McGeer E. The inflammatory response system of the brain: implications for therapy for Alzheimer’s disease and other neurodegenerative diseases. Brain Res Rev. 1995;21:195–218
  17. Roses AD. Apolipoprotein E, a gene with complex biological interactions in the aging brain. Neurobiol Dis. 1997;4:170–186
  18. Cassell C. Geriatric Medicine, 2nd edn. London: Springer-Verlag; 1990; p. 579–583
  19. Wisniewski K, Dalton AJ, McLachlan C. Alzheimer’s disease in Down syndrome: clinicopathological studies. Neurology. 1985;35:957–961
  20. Lemere C, Blusztag JK, Yamaguchi H. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis. 1996;3:16–22
  21. Diamond PT, Diamond MT. Thermoregulatory behavior in Alzheimer’s disease. J Am Ger Soc. 1991;39:552
  22. Okawa M, Mishima K, Hishikawa Y. Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia. Sleep. 1991;14:478–485
  23. Touitou Y, Reinberg A, Bowdan A. Age related changes in both circadian and seasonal rhythms of rectal temperature with special reference to senile dementia of Alzheimer’s type. Gerontology. 1986;32:110–118
  24. Hazama S, Takahat T, Kenshero E. Mild hypothermia in patients with senile dementia. Nippon Ronen Igakhu Zasshi. 1992;1:47–53
  25. Robinson D, Omar SJ, Quach M. Oral temperature changes and cognitive decline in Alzheimer’s patients: a possible association. J Am Ger Soc. 1994;42:1218–1219
  26. Brink T. Oral temperature and senile confusion; a response to Robinson. J Am Ger Soc. 1995;43:593
  27. McGeer PL, Schulzer M, McNeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease: a review of 17 epidemiologic studies. Neurology. 1996;47:425–432
  28. Murphy PJ, Myers BL, Badia P. Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans. Physiol Behav. 1996;59:133–139

PII: S0306-9877(00)91085-5

doi: 10.1054/mehy.2000.1085

Medical Hypotheses
Volume 55, Issue 5 , Pages 440-444 , November 2000

Article Tools